1. Home
  2. SEER

as of 12-04-2025 2:54pm EST

$1.90
+$0.01
+0.26%
Stocks Health Care Medicinal Chemicals and Botanical Products Nasdaq

Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.

Chart Type:
Time Range:
Founded: 2017 Country:
United States
United States
Employees: N/A City: REDWOOD CITY
Market Cap: 106.0M IPO Year: 2020
Target Price: N/A AVG Volume (30 days): 154.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.36 EPS Growth: N/A
52 Week Low/High: $1.62 - $2.59 Next Earning Date: 11-06-2025
Revenue: $16,376,999 Revenue Growth: 12.11%
Revenue Growth (this year): 25.97% Revenue Growth (next year): 24.00%

AI-Powered SEER Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 67.33%
67.33%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Seer Inc. (SEER)

Farokhzad Omid

CEO AND CHAIR

Sell
SEER Nov 19, 2025

Avg Cost/Share

$1.97

Shares

33,838

Total Value

$66,708.23

Owned After

1,238,230

SEC Form 4

Horn David R.

PRESIDENT & CFO

Sell
SEER Nov 19, 2025

Avg Cost/Share

$1.97

Shares

6,797

Total Value

$13,399.61

Owned After

436,802

SEC Form 4

Latest Seer Inc. News

SEER Breaking Stock News: Dive into SEER Ticker-Specific Updates for Smart Investing

All SEER News

Share on Social Networks: